6-Chloropyrido[3,4-d]pyrimidin-4(3H)-one, 95.0%, 250mg

2-Oxo-2,3-dihydrobenzo[d]oxazole-5-carbaldehyde, 98%, 100mg

Pyridine Hydrochloride>98.0%(HPLC)(T)500g

3-Chloro-4-(trifluoromethoxy)benzoic acid, 95.0%, 25g

3-Bromo-5-tert-butylphenylboronic acid, 98%, 5g

N-(2-sec-Butylphenyl)-2-chloropropanamide, 97%, 2g

Filtration unit with cellulose nitrate membrane Pore size 0.2 μm, without grid, 500 ml, 500 ml, 75 mm, 12 Piece(s)

5-(5,5-Dimethyl-1,3,2-dioxaborinan-2-yl)-1-methyl-1H-pyrazole, 97%, 1g

3-Bromo-4-(trifluoromethyl)benzoic acid, 95.0%, 5g

Ethyl 4-amino-3,5-difluorobenzoate, 95.0%, 5g

4-(4-(Methylsulfonyl)phenyl)piperidine, 95.0%, 250mg

1,1,2,2-Tetrafluoroethyl 2,2,3,3-Tetrafluoropropyl Ether>95.0%(GC)25g

2-Ethylaniline>98.0%(GC)(T)500mL